[HTML][HTML] Epidemiology of mucopolysaccharidoses update

B Celik, SC Tomatsu, S Tomatsu, SA Khan - Diagnostics, 2021 - mdpi.com
Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a
lysosomal enzyme deficiency or malfunction, which leads to the accumulation of …

[HTML][HTML] A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases

RM Leadley, S Lang, K Misso, T Bekkering… - Orphanet journal of rare …, 2014 - Springer
Abstract Background Morquio A (MPS IVA) is a rare disease characterised by a deficiency of
N-acetylgalactosamine-6 sulfatase (GALNS) and presenting with short stature, abnormal …

[HTML][HTML] Epidemiology of Sanfilippo syndrome: results of a systematic literature review

T Zelei, K Csetneki, Z Voko, C Siffel - Orphanet journal of rare diseases, 2018 - Springer
Background Sanfilippo syndrome (mucopolysaccharidosis [MPS] III subtypes A, B, C, and D)
is a rare autosomal recessive inherited metabolic disorder that causes progressive …

Efficient CRISPR/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA

AF Leal, CJ Alméciga-Díaz - Gene Therapy, 2023 - nature.com
Abstract Mucopolysaccharidosis IVA (MPS IVA) is a lysosomal storage disorder (LSD)
caused by mutations in gene encoding for GALNS enzyme. Lack of GALNS activity leads to …

[HTML][HTML] Delivery and assessment of a CRISPR/nCas9-based genome editing system on in vitro models of mucopolysaccharidoses IVA assisted by magnetite-based …

AF Leal, J Cifuentes, CE Torres, D Suárez… - Scientific Reports, 2022 - nature.com
Abstract Mucopolysaccharidosis IV A (MPS IVA) is a lysosomal disorder caused by
mutations in the GALNS gene. Consequently, the glycosaminoglycans (GAGs) keratan …

Estimated birth prevalence of mucopolysaccharidoses in Brazil

A Federhen, G Pasqualim, TF de Freitas… - American Journal of …, 2020 - Wiley Online Library
Several studies have been published on the frequency of the mucopolysaccharidoses
(MPS) in different countries. The objective of the present study was to estimate the birth …

[HTML][HTML] Evidence of epigenetic landscape shifts in mucopolysaccharidosis IIIB and IVA

V Vargas-López, LF Prada, CJ Alméciga-Díaz - Scientific Reports, 2024 - nature.com
Lysosomal storage diseases (LSDs) are a group of monogenic diseases characterized by
mutations in genes coding for proteins associated with the lysosomal function. Despite the …

Molecular characterization of mucopolysaccharidosis type IVA patients in the Andean region of Colombia

H Pachajoa, MA Acosta… - American Journal of …, 2021 - Wiley Online Library
Colombia has a high prevalence of mucopolysaccharidosis (MPS) type IVA. Nevertheless,
data regarding the mutation spectrum for MPS IVA in this population have not been …

Global epidemiology of mucopolysaccharidosis type III (Sanfilippo syndrome): an updated systematic review and meta-analysis

W Kong, S Wu, J Zhang, C Lu, Y Ding… - Journal of Pediatric …, 2021 - degruyter.com
Objectives Mucopolysaccharidosis III, an autosomal recessive lysosomal storage disorder, is
characterized by progressive mental retardation and behavioral problems. Meta-analysis of …

Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VII

F Kubaski, AC Brusius‐Facchin, RW Mason… - Prenatal …, 2017 - Wiley Online Library
Objective The aim of this study was to quantify glycosaminoglycans (GAGs) in amniotic fluid
(AF) from an MPS VII fetus compared with age‐matched fetuses obtained from normal …